| 2024-02-20 |
1 |
Complaint |
17 of 35
’507 patent”), 9,358,240 (“the ’240 patent”), 8,497,393 (“the ’393 patent”), 9,593,066 (“the…066 patent, the ’901 patent, the ’793 patent, and U.S. Patent No. 10,376,525 (“the
’525 patent”). See United… Patent Data
Patent No. Patent Drug Drug Patent Delist …to FDA
regarding U.S. Patent No. 10,716,793 (“the ’793 patent”). The ’793 patent was timely submitted
…Orange Book patent information for TYVASO—specifically, to the ’507 patent, the
’240 patent, the ’066 |
External link to document |
| 2024-03-04 |
12 |
Exhibit A |
of1835of 36
’507 patent”), 9,358,240 (“the ’240 patent”), 8,497,393 (“the ’393 patent”), 9,593,066 (“the…066 patent, the ’901 patent, the ’793 patent, and U.S. Patent No. 10,376,525 (“the
’525 patent”). See United… Patent Data
Patent No. Patent Drug Drug Patent Delist …to FDA
regarding U.S. Patent No. 10,716,793 (“the ’793 patent”). The ’793 patent was timely submitted
…Orange Book patent information for TYVASO—specifically, to the ’507 patent, the
’240 patent, the ’066 |
External link to document |
| 2024-03-18 |
23 |
Exhibit 3 |
Orange Book patents — U.S. Patent Nos. 9,339,507 (“’507 patent”), 9,358,240 (“ʼ240 patent”),
9,593,066…Letter points to three patents, the ’793 patent, the ’887 patent, and the ’327 patent,
all issuing after …act of patent
infringement” of the applicable patent(s) at issue, which in turn can trigger patent infringement…Orange Book patents for TYVASOTM:
the ʼ507, ʼ240, ʼ066, ʼ901, ʼ793 patents and U.S. Patent No. 10,376,…regarding the ʼ887 patent.
On November 28, 2023, U.S. Patent No. 11,826,327 (“’327 patent”) issued to |
External link to document |
